TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/23/2026 12:43 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $26.41. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $290,970 vs put $3,970. RSI 19.2.
- Symbol
- ACAD
- Price
- $26.41
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-23 12:43:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume:
| Call Volume | Put Volume |
|---|---|
| $290,970 | $3,970 |
The options flow suggests bullish sentiment, with a high call-to-put ratio.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 11.84 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 6.96 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports strong quarterly earnings, beating analyst expectations.
- ACADIA Pharmaceuticals faces increased competition in the pharmaceutical industry.
These headlines may impact the stock's price action and sentiment. The FDA approval and strong earnings report could be positive catalysts, while increased competition could be a negative factor.
Fundamental Analysis:
Based on the provided fundamentals data:
- Total Revenue: $11,386,430,000
- Trailing EPS: $2.23
- Trailing P/E: 11.84
- Price-to-Book: 6.96
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
The company's revenue and EPS are strong, with a relatively low P/E ratio. However, the high price-to-book ratio and debt-to-equity ratio may be concerns.
Current Market Position:
Current price: $25.07
Recent price action: The stock has been trending downward, with a recent low of $25.07.
Key support and resistance levels:
| Level | Price |
|---|---|
| Support | $25.00 |
| Resistance | $28.00 |
Technical Analysis:
SMA trends:
| SMA | Price |
|---|---|
| 5-day SMA | $26.52 |
| 20-day SMA | $27.81 |
| 50-day SMA | $27.62 |
RSI (14): 19.22, indicating oversold conditions.
MACD: -0.55, signaling a bearish trend.
Bollinger Bands: The stock is trading near the lower band, indicating potential for a bounce.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume:
| Call Volume | Put Volume |
|---|---|
| $290,970 | $3,970 |
The options flow suggests bullish sentiment, with a high call-to-put ratio.
Key Price Levels:
Support: $25.00
Resistance: $28.00
Entry: $25.50
Target: $28.50
Stop Loss: $24.50
25-Day Price Forecast:
Based on current trends and indicators, ACAD is projected for $26.50 to $30.00.
This range is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility.
Defined Risk Strategy Recommendations:
Based on the price forecast, here are three defined risk strategy recommendations:
- Bull Call Spread: Buy the $27.50 call and sell the $30.00 call, expiring on 2026-10-16.
- Iron Condor: Sell the $25.00 put, buy the $27.50 put, sell the $30.00 call, and buy the $32.50 call, expiring on 2026-10-16.
- Protective Put: Buy the $25.00 put, expiring on 2026-10-16.
Risk Factors:
Technical warning signs:
- Bearish MACD signal
- Oversold RSI conditions
Sentiment divergences:
- Bullish options flow vs bearish technicals
Volatility and ATR considerations:
- Recent increase in volatility
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: Buy ACAD with a bullish bias, targeting $28.50.
View ACAD Options Chain